OpenAlex
PricingAboutJobs
Log inGet started
Work

Rhabdomyolysis with HMG‐CoA reductase inhibitors and gemfibrozil combination therapy

HTML

Year: 2004
Type: article
Study design: Observational Study
Source: Pharmacoepidemiology and Drug Safety
DOI: 10.1002/pds.977
Authors: Jennie T. Chang, Judy A. Staffa, Mary Parks, Lanh Green
Institution: United States Food and Drug Administration
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rhabdomyolysis, statins, gemfibrozil, statin-fibrate combination therapy, adverse drug reactions, drug safety, FDA Adverse Event Reporting System, reporting rates, cerivastatin, renal failure, creatine kinase, lipid-lowering therapy, drug interactions, post-marketing surveillance, cardiovascular risk factors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2102504779
FWCI: 11.6
Cites: 15
Cited by: 159
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security